OBR Resources
- OBR Journal Articles
- OBR Daily eNews
- Recent Blog Entries
Feature Articles
Oncology Business Review is our industry trade journal with carefully developed, exclusive oncology industry content.
SUBSCRIBE to Oncology Business Review Journal Today!
Perceptions in Oncology Drug Strengths and Weaknesses: Zitter Group Survey Shows Similarities and Disparities Between Payers and Providers
July 1st
[ read article ]As the Importance of Biomarkers Increases, Academia and Industry Consider How Best to Respond
July 1st
[ read article ]The Physician’s Role in Securing Patient Access to Appropriate Therapies: Sharing the Stage with Patients and Payers
July 1st
[ read article ]ASCO '08: Media, Giveaways, and Foot Traffic
July 1st
[ read article ]ASCO '08: A Look at the Progress in 3 Different Cancer Types
July 1st
[ read article ]ASCO '08: The Competition for Share of Voice Descends Upon Chicago,
July 1st
[ read article ]ON-CONOMY: Medicare Policies Change ESA Use and Payment
July 1st
[ read article ]Read ALL Articles » | Read ARCHIVED Articles »
Top Headlines - Fri Sep 05, 2008
Oncology News Headlines
The Cancer Genome Atlas Reports First Results of Comprehensive Study of Brain Tumors: Large-Scale Effort Identifies New Genetic Mutations, Core Pathways
(NCI) Sept 4, 2008 - The Cancer Genome Atlas (TCGA) Research Network, a collaborative effort funded by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH), today reported the first results of its large-scale, comprehensive study of the most common form of brain cancer, glioblastoma (GBM).
read press release »
Cytopia Commences Second Phase II Study in Brain Cancer
(StreetInsider.com) Sept 4, 2008 - Cytopia Limited today announced that it is commencing enrollment for its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, in patients with an aggressive form of brain cancer known as glioblastoma multiforme (GBM).
read article »
ZIOPHARM Commences Randomized Phase II Study of Palifosfamide in Soft Tissue Sarcoma
(Yahoo! Finance) Sept 5, 2008 - ZIOPHARM Oncology, Inc., announced today that the first patient has been dosed in its international Phase II randomized controlled trial of palifosfamide (ZIO-201) in patients with soft-tissue sarcoma (STS).
read article »
Read ALL Oncology Headlines »
Pharma/Biotech News Headlines
FDA Posts List of Potential Problem Drugs
(New York Times) Sept 5, 2008 - In an effort to improve communication with doctors and patients on prescription drug safety, the government Friday began posting a list of medications under investigation for potential problems.
read article (free registration required) »
Outsourcing the Drug Industry
(BusinessWeek.com) Sept 4, 2008 - In her swank headquarters just blocks from some of Mumbai's worst slums, Swati Piramal is midway through an impassioned pitch about revolutionizing the world of drug discovery.
read article »
Roche Molecular Diagnostics Wins FDA OK for Hepatitis B Test
(San Francisco Business Times) Sept 4, 2008 - A hepatitis B viral load test, developed by Roche Molecular Diagnostics in Pleasanton, was approved by the Food and Drug Administration.
read article »
